Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Australie (1)
Care Delivery/ Care pathway
Neurology/Parkinson's Disease (1)
Insurance Company (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Continuity and sustainability
Clinical study phase I